Drug
Xl019
Xl019: highest development phase Phase 1, developed by Exelixis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Exelixis
Trials
| Drug | Phase | Indication |
|---|---|---|
| XL019 NCT00595829 | Phase 1 | Polycythemia Vera |
Latest
No recent events.
Follow Xl019 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.